A detailed history of Israel Englander (Millennium Management LLC) transactions in Cara Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 587,909 shares of CARA stock, worth $176,372. This represents 0.0% of its overall portfolio holdings.

Number of Shares
587,909
Previous 586,755 0.2%
Holding current value
$176,372
Previous $152,000 19.74%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.26 - $0.38 $300 - $438
1,154 Added 0.2%
587,909 $182,000
Q2 2024

Aug 14, 2024

SELL
$0.24 - $0.92 $18,018 - $69,072
-75,079 Reduced 11.34%
586,755 $152,000
Q1 2024

May 15, 2024

BUY
$0.52 - $1.05 $101,216 - $204,379
194,647 Added 41.66%
661,834 $602,000
Q4 2023

Feb 14, 2024

SELL
$0.6 - $1.65 $166,590 - $458,122
-277,650 Reduced 37.28%
467,187 $345,000
Q2 2023

Aug 14, 2023

BUY
$2.83 - $4.94 $2.07 Million - $3.62 Million
732,330 Added 5855.36%
744,837 $2.11 Million
Q1 2023

May 15, 2023

SELL
$4.89 - $12.27 $28,410 - $71,288
-5,810 Reduced 31.72%
12,507 $61,000
Q4 2022

Feb 14, 2023

BUY
$8.88 - $12.77 $162,654 - $233,908
18,317 New
18,317 $197,000
Q2 2022

Aug 15, 2022

BUY
$7.45 - $13.84 $5.8 Million - $10.8 Million
778,186 New
778,186 $7.11 Million
Q4 2021

Feb 14, 2022

SELL
$11.99 - $18.14 $432,371 - $654,146
-36,061 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$11.55 - $16.06 $416,504 - $579,139
36,061 New
36,061 $557,000
Q2 2021

Aug 16, 2021

SELL
$12.38 - $29.19 $621,575 - $1.47 Million
-50,208 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$15.07 - $21.71 $1.78 Million - $2.56 Million
-118,105 Reduced 70.17%
50,208 $1.09 Million
Q4 2020

Feb 16, 2021

BUY
$12.72 - $16.16 $1.96 Million - $2.5 Million
154,480 Added 1116.75%
168,313 $2.55 Million
Q3 2020

Nov 16, 2020

SELL
$12.34 - $17.92 $1.14 Million - $1.65 Million
-92,321 Reduced 86.97%
13,833 $176,000
Q2 2020

Aug 14, 2020

BUY
$12.39 - $17.33 $1.32 Million - $1.84 Million
106,154 New
106,154 $1.82 Million
Q1 2020

May 14, 2020

SELL
$9.12 - $17.78 $362,009 - $705,759
-39,694 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$16.11 - $25.98 $639,470 - $1.03 Million
39,694 New
39,694 $639,000
Q3 2019

Nov 14, 2019

SELL
$18.28 - $26.91 $1.03 Million - $1.52 Million
-56,607 Closed
0 $0
Q2 2019

Aug 15, 2019

SELL
$17.68 - $21.57 $19.4 Million - $23.7 Million
-1,097,779 Reduced 95.1%
56,607 $1.22 Million
Q2 2019

Aug 14, 2019

BUY
$17.68 - $21.57 $20 Million - $24.4 Million
1,128,889 Added 4427.54%
1,154,386 $55.3 Million
Q1 2019

May 14, 2019

SELL
$14.41 - $19.64 $4.16 Million - $5.67 Million
-288,848 Reduced 91.89%
25,497 $500,000
Q4 2018

Feb 14, 2019

SELL
$12.45 - $23.47 $92,316 - $174,030
-7,415 Reduced 2.3%
314,345 $4.09 Million
Q3 2018

Nov 14, 2018

BUY
$17.57 - $23.95 $4.64 Million - $6.32 Million
263,863 Added 455.75%
321,760 $7.71 Million
Q2 2018

Aug 14, 2018

BUY
$11.6 - $19.27 $671,605 - $1.12 Million
57,897 New
57,897 $1.11 Million
Q1 2018

May 15, 2018

SELL
$11.77 - $16.08 $1.32 Million - $1.8 Million
-112,222 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$11.86 - $14.08 $1.1 Million - $1.31 Million
92,841 Added 479.03%
112,222 $1.37 Million
Q3 2017

Nov 14, 2017

BUY
$12.6 - $16.34 $244,200 - $316,685
19,381
19,381 $265,000

Others Institutions Holding CARA

About Cara Therapeutics, Inc.


  • Ticker CARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,725,900
  • Market Cap $16.1M
  • Description
  • Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...
More about CARA
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.